Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2020

Feb 28, 2020

29995_dirs_2020-02-27_8d72fe30-a196-4861-bd0d-b84af986d9bc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2020-02-25

Reporting Person: Khalaf Michel (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-25 Common Stock A 17558 Acquired 40138 Direct
2020-02-25 Common Stock D 17558 $47.58 Disposed 22580 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-25 Employee Stock Options (right to buy) $47.58 A 94578 Acquired 2030-02-24 Common Stock (94578.0) Direct
2020-02-25 Restricted Stock Units $ A 31526 Acquired Common Stock (31526.0) Direct

Footnotes

F1: Cash payout of 2017-2019 performance units, following determination of the performance factor for such award. Each performance unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date.

F2: The options become exercisable in equal installments on each of the first three anniversaries of the grant date.

F3: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock.

F4: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.